Interestingly, a study in breast cancer indicated that the expression level of serum exosomal-annexin A2 (exo-AnxA2) could be detected higher in women with carcinoma compared with non-cancer, particularly for triple-negative breast cancer (TNBC) rather than luminal or HER2-positive breast cancer35. Here, ANXA2 is linked to cancer.